HANCOM LIFECARE INC. Financials Hancom Lifecare Inc.
Equities
A372910
KR7372910000
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,290 KRW | -1.87% |
|
-3.38% | +38.70% |
| 2023 | Hancom Lifecare Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2021 | Hancom Lifecare Inc. has completed an IPO in the amount of KRW 113.741798 billion. | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Capitalization 1 | 161,895 | 125,503 | 174,072 | - |
| Enterprise Value (EV) 2 | 161.9 | 125.5 | 162.5 | 161.5 |
| P/E ratio | - | - | 32.8 x | 27.1 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 1.62 x | 1.1 x | 1.46 x | 1.32 x |
| EV / Revenue | 1.62 x | 1.1 x | 1.36 x | 1.23 x |
| EV / EBITDA | - | - | 10.6 x | 9.5 x |
| EV / FCF | - | - | 108 x | 147 x |
| FCF Yield | - | - | 0.92% | 0.68% |
| Price to Book | - | - | 1.32 x | 1.25 x |
| Nbr of stocks (in thousands) | 27,674 | 27,674 | 27,674 | - |
| Reference price 3 | 5,850 | 4,535 | 6,290 | 6,290 |
| Announcement Date | 3/15/23 | 1/22/24 | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net sales 1 | 100.1 | 113.6 | 119.5 | 131.4 |
| EBITDA 1 | - | - | 15.3 | 17 |
| EBIT 1 | - | 2.562 | 8.4 | 10.1 |
| Operating Margin | - | 2.26% | 7.03% | 7.69% |
| Earnings before Tax (EBT) 1 | - | 1.545 | 8 | 9.6 |
| Net income 1 | 9.204 | 1.616 | 5.3 | 6.4 |
| Net margin | 9.19% | 1.42% | 4.44% | 4.87% |
| EPS 2 | - | - | 192.0 | 232.0 |
| Free Cash Flow 3 | - | - | 1,500 | 1,100 |
| FCF margin | - | - | 1,255.23% | 837.14% |
| FCF Conversion (EBITDA) | - | - | 9,803.92% | 6,470.59% |
| FCF Conversion (Net income) | - | - | 28,301.89% | 17,187.5% |
| Dividend per Share | - | - | - | - |
| Announcement Date | 3/15/23 | 1/22/24 | - | - |
1KRW in Billions2KRW3KRW in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|
| Net sales 1 | 9.4 | 38.7 | 22.4 | 48.9 |
| EBITDA | - | - | - | - |
| EBIT 1 | -3 | 7.6 | 1.9 | 1.9 |
| Operating Margin | -31.91% | 19.64% | 8.48% | 3.89% |
| Earnings before Tax (EBT) 1 | -2.9 | 7.2 | 1.8 | 1.8 |
| Net income 1 | -2 | 4.9 | 1.2 | 1.2 |
| Net margin | -21.28% | 12.66% | 5.36% | 2.45% |
| EPS | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | - | - | - | - |
1KRW in Billions
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | - | - | 11.6 | 12.6 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow 2 | - | - | 1,500 | 1,100 |
| ROE (net income / shareholders' equity) | - | 1.26% | 4.1% | 4.7% |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share 3 | - | - | 4,781 | 5,012 |
| Cash Flow per Share | - | - | - | - |
| Capex 1 | - | - | 5.7 | 6.3 |
| Capex / Sales | - | - | 4.77% | 4.79% |
| Announcement Date | 3/15/23 | 1/22/24 | - | - |
1KRW in Billions2KRW in Million3KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +38.70% | 129M | |
| -2.54% | 187B | |
| -1.85% | 106B | |
| -4.26% | 66.9B | |
| +1.39% | 49.45B | |
| +16.82% | 48B | |
| +6.01% | 40.84B | |
| +3.49% | 26.48B | |
| +0.65% | 26.25B | |
| +17.74% | 24.62B |
- Stock Market
- Equities
- A372910 Stock
- Financials Hancom Lifecare Inc.
